The PMPCA gene helps cells prepare many proteins for work inside mitochondria, the parts of cells that make energy. If it does not work properly, those proteins are not processed as they should be, and cells can struggle to make enough energy. Rare pathogenic variants in the PMPCA gene are linked to inherited mitochondrial conditions that may affect movement, muscle tone, learning, feeding, or the brain. Most variants in this gene have little effect on how your body works.
What is a gene?
Genes are stretches of DNA that give cells instructions for making molecules or for regulating processes in the body. Some genes carry the directions for producing proteins, which serve as the working parts of cells. Other genes are used mainly to control when certain processes take place, where they happen, and how strongly they run. Together, genes affect how the body develops and functions, and they can shape how you respond to food, stress, or medications. More information on this topic is available in the LearnHub.
Overview
PMPCAGene function
What if the gene works
The PMPCA gene helps mitochondria, the parts of cells that make energy, process imported proteins so they can work properly. This supports normal energy production, especially in muscles and the nervous system.
Risk
What if the gene does not work
Pathogenic variants in the PMPCA gene can disrupt mitochondrial energy production. More severe variants often cause early-onset mitochondrial disease with low muscle tone, developmental delay, seizures, and feeding problems, while milder variants may lead to progressive balance and coordination difficulties.
Treatment
What does that mean for your treatment
No PMPCA-specific treatment or management approach is currently established, so care is based on a person’s symptoms and overall clinical needs rather than on a targeted drug choice linked to the PMPCA gene.
Conditions associated with PMPCA
Gene function
What if the gene works
Inside your cells, the PMPCA gene helps proteins get ready for work inside mitochondria, the parts of cells that make much of your energy. Its protein acts as a finishing step after these proteins arrive. Understanding what the PMPCA gene does helps explain how cells keep everyday energy processes running smoothly.
The PMPCA gene helps remove short leader pieces from proteins after they enter mitochondria. This step helps many mitochondrial proteins become mature and ready to work.
Its protein joins with the PMPCB protein to form mitochondrial processing peptidase, a protein-cutting enzyme. Together they process many proteins that are made outside mitochondria and finished inside them.
By helping mitochondria prepare many of their proteins, the PMPCA gene supports steady energy production. This helps cells carry out routine jobs such as movement, signaling, and growth.
What is a variant?
A genetic variant is a small change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many PMPCA gene variants alter how the PMPCA protein recognizes or holds newly imported proteins in mitochondria, the parts of cells that help make energy. Milder variants may leave some activity, while more severe variants can greatly reduce or stop this processing step and disrupt protein maturation inside mitochondria. In people with disease-causing PMPCA gene variants, less remaining activity often relates to earlier onset and more wide-ranging features.
How variants are linked to conditions
Pathogenic variants in both copies of the PMPCA gene cause combined oxidative phosphorylation deficiency 31, a rare inherited mitochondrial condition. In reports describing conditions linked to variants in the PMPCA gene, affected people may have developmental delay, low muscle tone, seizures, feeding problems, and trouble with balance and coordination. Some have a severe illness beginning in infancy, while others mainly develop cerebellar ataxia, showing that this condition can vary widely.
A variant is not necessarily a diagnosis
Genetic variants are common in the general population and are a normal part of human biology. Most do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental factors contribute. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For PMPCA, risk is mainly linked to whether someone inherits disease-causing changes in both copies of the gene, usually one from each parent. There is not yet broadly confirmed evidence that specific lifestyle or environmental factors clearly increase or reduce risk related to PMPCA, so anyone worried about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of PMPCA variants
PMPCA-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one PMPCA gene variant from each parent, and the parents are typically healthy carriers. When both parents carry a variant, each pregnancy has a 25% chance of resulting in an affected child, a 50% chance of a child being a carrier, and a 25% chance of a child inheriting neither variant. In practical terms, how PMPCA gene variants are inherited is the same for sons and daughters, and either parent can pass on the changed copy.
What does my PMPCA result mean for my family?
For families, PMPCA results usually matter in a recessive pattern, which means parents can carry a changed copy without being affected, and brothers and sisters may also be affected or be carriers. Close relatives may want to learn whether the same gene change runs in the family, especially if there are similar symptoms such as balance problems, muscle weakness, or developmental delays. The exact meaning depends on the specific result and the condition linked to it.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the PMPCA gene, doctors use genetic testing for PMPCA variants on a blood, saliva, or cheek swab sample. A lab reads the DNA code to look for variants that may help confirm a diagnosis, explain symptoms, or show whether a variant runs in a family.
When should I consider getting a genetic test?
Genetic testing for the PMPCA gene may be considered when a child or adult has signs of a rare inherited condition that affects the body’s energy production, such as developmental delay, seizures, poor balance, muscle weakness, or vision problems. It can also help clarify the cause when similar symptoms run in the family.
A genetic result is only one part of your health story
Genetic results can provide useful insight, yet how much they clarify varies with the condition and the kind of variant present. Many factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, these results may help place individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment may work well for one person, seem weaker for another, or cause more side effects in someone else. One reason is that inherited differences can change how the body breaks down, moves, or responds to a drug, which can influence both benefit and sensitivity.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the response to medications. It studies the relationship between genes and drugs to better explain why treatments work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed, individualized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the PMPCA gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so medication questions, side effects, or concerns that a treatment is not helping are best discussed with your doctor.
History
PMPCA entered the scientific literature through research on how mitochondria, the cell’s energy producing structures, handle newly made proteins. In the 1980s and 1990s, scientists studying mitochondrial protein import identified the alpha subunit of mitochondrial processing peptidase, which is encoded by the PMPCA gene. From these first observations, research expanded steadily. Over time, PMPCA was recognized not only as part of basic cell biology but also as a gene linked to inherited neurologic conditions. Reports in the 2010s connected pathogenic variants in the PMPCA gene with childhood onset problems such as changes in movement, muscle tone, and brain development. This shifted PMPCA from a lab based discovery to a gene with clear clinical relevance.